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Mitochondria are intracellular organelle playing central roles in intracellular energy
metabolism and reactive oxygen species (ROS) production. Recently, much attention
has been focused on the role of mitochondria in the mechanisms of cardiovascular
and metabolic diseases such as atherosclerosis, heart failure, hypertension, and diabetes.
Mitochondrial metabolism, such as ATP production via β-oxidation, TCA cycle to
generate metabolites, and mitochondrial electron transport chain to generate ROS,
is essential for normal cell function. Of note, vascular endothelial cells mainly
depend on glycolysis to produce ATP in normal physiological conditions. Although
ROS at the physiological level are important for cell signaling, excess ROS derived
from dysfunctional mitochondria promote cardiovascular diseases (1). In addition,
mitochondrial autophagy (mitophagy) plays an important role in mitochondrial quality
control by removing damaged mitochondria (2). Mitochondrial dynamics regulated
by the balance of mitochondrial fission and fusion is important for maintaining
mitochondrial function and health. Emerging evidence suggests that mitochondrial
dysfunction, aberrations in mitochondrial metabolism, ROS levels and dynamics, and
impaired mitophagy are interconnected, which contributes to the pathophysiology of
cardiovascular diseases.
This Research Topic highlighted three original papers and three review articles in this
area. Shosha et al. examined the metabolic function and mitochondrial structure in the
retinas of control and diabetic mice. They demonstrated mitochondria fragmentation
in the retina of middle-aged diabetic Akita mice, which was associated with a decrease
in glycolysis and expression of 6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase 3
(PFKFB3), a rate-limiting enzyme of glycolysis, in the retina. However, these changes
were not observed in old Akita mice at 10 months of age. As the authors have
mentioned, the role of age-specific suppression of glycolysis in the pathobiology of
diabetic retinopathy needs to be further examined. Mitochondrial respiratory function
determined by oxygen consumption rate (OCR) measurement showed no significant
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smooth muscle cells are suppressed, indicating that FAT1 is
a potential therapeutic target for mitochondria-dependent
vascular disease. Zeng et al. summarized a review focusing
on the role of mitochondria in the process of vascular
calcification. First, they briefly summarized the mechanisms
of vascular calcification. Then, they discussed the role of
mitochondria in vascular calcification and related mechanisms.
For example, mitochondria are involved in intracellular
calcium homeostasis and cell death, including apoptosis,
which is considered relevant to the pathogenesis of vascular
calcification. The article also stated that the accumulation
of mitochondrial damage and inhibition of mitophagy, a
mitochondrial removal mechanism, can lead to mitochondrial
dysfunction and smooth muscle cell calcification. Lastly,
they discussed future research directions and the main
challenges. Uchikado et al. summarized the topic focused
on mitochondrial dynamics and cardiovascular diseases.
Recent evidence supports the hypothesis that mitochondrial
morphological changes, including fission and fusion, play an
important role in mitochondrial quality control mechanisms
(4). Impairment of these processes is related to various
cardiovascular senescence/diseases (5).
This Research Topic supports the notion that mitochondria
have emerged as central factors in various aspects of
cardiovascular diseases. Although this multifaceted nature
of mitochondria can be an obstacle in therapeutic development,
understanding and identifying key molecules involved in
mitochondrial dysfunction will lead to developing novel
effective therapies and targets required for the treatment of
various cardiovascular diseases.

differences between the Akita and control mice. However, basal
respiratory activity was decreased in Akita mice under glucosefree conditions, suggesting that the metabolic stress induced
by glucose deprivation and subsequent glycolysis inhibition
can unmask mitochondrial dysfunction in the diabetic retinas.
Future studies are needed to elucidate mechanisms underlying
the difference in mitochondrial respiration under glucose or
glucose-deprived conditions.
Ma et al. reported the role of iron in the mechanisms
of atherosclerosis. Authors have observed increased iron
content in the aorta of apolipoprotein-E−/− (ApoE−/− ) mice,
accompanied by increased expression of transferrin receptor 1,
ferritin, iron regulatory protein 1, iron regulatory protein 2, and
heme oxygenase 1, all of which are related to iron metabolism.
In addition, they found that ApoE−/− mice had an increased
expression of aortic ICAM1, VCAM1, LOX-1, Gpx4, and CD36,
as well as increased levels of ROS in the blood. Importantly,
deferoxamine, an iron chelator, abrogated atherosclerotic plaque
formation and suppressed the induction of iron metabolismsrelated molecules. The authors concluded that the increased
uptake of iron and its accumulation in the aortic wall at
least partially promote the development of atherosclerosis in
ApoE−/− mice, likely through iron-mediated production of
ROS. It is reported that mitochondria play important roles in
intracellular iron metabolisms. For example, the final step of
heme biosynthesis occurs in the mitochondrial matrix (3). The
importance of iron metabolism in the cardiovascular systems is
largely unknown. Thus, further studies are warranted to develop
anti-atherosclerosis therapies targeting iron metabolism.
Dikalov et al. reported a novel, 15 N- and deuteriumenriched spin probe 15 N-CAT1H, a highly sensitive and sitespecific probe for extracellular superoxide. In combination
with 14 N-mitoTEMPO, phagocytic NADPH oxidase activity
and mitochondrial superoxide were visualized in immune cells
isolated from the spleen. Using these probes, the authors
demonstrated the coupling of phagocytic NADPH oxidase
activity and mitochondrial superoxide production. In splenic
immune cells isolated from angiotensin II-infused mice, basal
superoxide level was increased. The complex III inhibitor,
mitochondrial uncoupler, and NADPH oxidase activator
further increased superoxide levels in both extracellular
space and mitochondria, suggesting angiotensin II-induced
superoxide production by the cross-talk between NADPH
oxidase and mitochondria.
The three reviews summarize up-to-date information about
mitochondria’s role in cardiovascular diseases. Riascos-Bernal
et al. described atypical cadherin FAT1. They have reported that
FAT1 is an unpredicted negative regulator of mitochondrial
function, including mitochondrial metabolism, and suppresses
smooth muscle cell proliferation after vascular injury. In
addition, FAT1 interacts with the electron transport chain
complexes and suppresses mitochondrial respiration. As a
result of this action, DNA synthesis and proliferation of
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